Cite
HARVARD Citation
Dodick, D. et al. (n.d.). A.07 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE I. Canadian journal of neurological sciences. pp. S9-S10. [Online].